Prostaglandin D synthase does not produce prostate-specific antigen cross-reactivity in renal cell carcinoma

被引:0
|
作者
Bulmer, B
Ward, G
Diamandis, E
Nicol, D
Clements, J
机构
[1] Queensland Univ Technol, Sch Life Sci, Ctr Mol Biotechnol, Brisbane, Qld 4001, Australia
[2] Princess Alexandra Hosp, Dept Chem Pathol, Woolloongabba, Qld 4102, Australia
[3] Princess Alexandra Hosp, Dept Urol, Woolloongabba, Qld 4102, Australia
[4] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[5] Queensland Univ Technol, Sch Life Sci, Cooperat Res Ctr Diagnost Technol, Brisbane, Qld 4001, Australia
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:607 / 608
页数:2
相关论文
共 50 条
  • [21] Progression from adenocarcinoma to small cell carcinoma of the prostate with normalization of prostate-specific antigen (PSA) levels
    Valle, J
    vonBoguslawsky, K
    Stenborg, M
    Andersson, LC
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1996, 30 (06): : 509 - 512
  • [22] Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein - Comment
    Rittenhouse, HG
    Wolfert, RL
    Wang, TJ
    [J]. UROLOGY, 1997, 50 (04) : 571 - 572
  • [23] Prostate-specific membrane antigen expression in endothelial cells of renal tumor-associated neovasculature and risk of recurrence for renal cell carcinoma.
    Kagimoto, Keito
    Watanabe, Ryuta
    Miura, Noriyoshi
    Saika, Takashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 377 - 377
  • [24] Expression of prostate specific membrane antigen (PSMA) in subtypes of renal cell carcinoma
    Al-Ahmadie, HA
    Olgac, S
    Gregor, P
    Reuter, VE
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 125A - 125A
  • [25] Expression of prostate specific membrane antigen (PSMA) in subtypes of renal cell carcinoma
    Al-Ahmadie, HA
    Olgac, S
    Gregor, P
    Reuter, VE
    [J]. MODERN PATHOLOGY, 2005, 18 : 125A - 125A
  • [26] Development of monoclonal antibodies specific for human glandular kallikrein (hK2): Development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity
    Finlay, JA
    Evans, CL
    Day, JR
    Payne, JK
    Mikolajczyk, SD
    Millar, LS
    Kuus-Reichel, K
    Wolfert, RL
    Rittenhouse, HG
    [J]. UROLOGY, 1998, 51 (05) : 804 - 809
  • [27] DIAGNOSTIC VALUE OF 68GA-LABELLED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) PET/CT IMAGING FOR RENAL CELL CARCINOMA
    Zhang, Chengwei
    Zhao, Xiaozhi
    Shiming, Zang
    Wang, Feng
    Guo, Hongqian
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E456 - E456
  • [28] Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
    Shivanshan Pathmanathan
    Arsalan Tariq
    Adam Pearce
    Handoo Rhee
    Samuel Kyle
    Sheliyan Raveenthiran
    David Wong
    Rhiannon McBean
    Phillip Marsh
    Steven Goodman
    Nattakorn Dhiantravan
    Rachel Esler
    Nigel Dunglison
    Anojan Navaratnam
    John Yaxley
    Paul Thomas
    David A. Pattison
    Jeffrey C. Goh
    Chun Loo Gan
    Matthew J. Roberts
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 51 : 295 - 303
  • [29] Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
    Pathmanathan, Shivanshan
    Tariq, Arsalan
    Pearce, Adam
    Rhee, Handoo
    Kyle, Samuel
    Raveenthiran, Sheliyan
    Wong, David
    McBean, Rhiannon
    Marsh, Phillip
    Goodman, Steven
    Dhiantravan, Nattakorn
    Esler, Rachel
    Dunglison, Nigel
    Navaratnam, Anojan
    Yaxley, John
    Thomas, Paul
    Pattison, David A.
    Goh, Jeffrey C.
    Gan, Chun Loo
    Roberts, Matthew J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 51 (01) : 295 - 303
  • [30] Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC).
    Pathmanathan, Shivanshan
    Tariq, Arsalan
    Gan, Chun Loo
    Pearce, Adam
    Rhee, Handoo
    Kyle, Samuel
    Raveenthiran, Sheliyan
    Wong, David
    McBean, Rhiannon
    Marsh, Philip
    Goodman, Steven
    Dhiantravan, Nattakorn
    Esler, Rachel
    Dunglison, Nigel
    Navaratnam, Anojan
    Yaxley, John
    Thomas, Paul
    Pattison, David A.
    Goh, Jeffrey C.
    Roberts, Matthew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)